2021
DOI: 10.1021/acs.jmedchem.1c00913
|View full text |Cite
|
Sign up to set email alerts
|

Imaging Autotaxin In Vivo with 18F-Labeled Positron Emission Tomography Ligands

Abstract: Autotaxin (ATX) is a secreted phosphodiesterase that has been implicated in a remarkably wide array of pathologies, especially in fibrosis and cancer. While ATX inhibitors have entered the clinical arena, a validated probe for positron emission tomography (PET) is currently lacking. With the aim to develop a suitable ATX-targeted PET radioligand, we have synthesized a focused library of fluorinated imidazo­[1,2-a]­pyridine derivatives, determined their inhibition constants, and confirmed their binding mode by … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…Suppression of the enzymes responsible for defluorination by pre-injecting an extraneous enzyme inhibitor prior to the liable PET ligand has been shown to be viable in reducing bone uptake in both rats and humans in the case of the 5-HT 1A receptor ligand 18 F-CWAY. However, a preferred approach would be to eliminate the defluorination pathway with minimal modification of the parent structure. Deuterium substitution adjacent to a labile fluorine atom has proven to be an effective means to improve the metabolic stability of both therapeutic candidates and 18 F-PET tracers. Accordingly, we synthesized the tetra-deutero analogue ( 19 , 98% d 4 ) with the prediction that the kinetic isotope effect would slow the defluorination metabolic pathway anticipated in 18 . As expected from the bioisosteric nature of H→D exchange, 19 maintained lipophilicity (eLogD) and free brain fraction ( f u,b ) similar to those of 18 .…”
Section: Resultsmentioning
confidence: 99%
“…Suppression of the enzymes responsible for defluorination by pre-injecting an extraneous enzyme inhibitor prior to the liable PET ligand has been shown to be viable in reducing bone uptake in both rats and humans in the case of the 5-HT 1A receptor ligand 18 F-CWAY. However, a preferred approach would be to eliminate the defluorination pathway with minimal modification of the parent structure. Deuterium substitution adjacent to a labile fluorine atom has proven to be an effective means to improve the metabolic stability of both therapeutic candidates and 18 F-PET tracers. Accordingly, we synthesized the tetra-deutero analogue ( 19 , 98% d 4 ) with the prediction that the kinetic isotope effect would slow the defluorination metabolic pathway anticipated in 18 . As expected from the bioisosteric nature of H→D exchange, 19 maintained lipophilicity (eLogD) and free brain fraction ( f u,b ) similar to those of 18 .…”
Section: Resultsmentioning
confidence: 99%